Chromosomal radiosensitivity of breast cancer with a CHEK2 mutation

Cancer Genetics and Cytogenetics

Volumn 163, Issue 2, 2005, Pages 106-112

  Baeyens, Ans ^a   Claes, Kathleen ^b   Willems, Petra ^a   De Ruyck, Kim ^a   Thierens, Hubert ^a   Vral, Anne ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 2; MUTANT PROTEIN;

ARTICLE; BREAST CANCER; CANCER PATIENT; CHROMATID; CHROMOSOME BREAKAGE; CONTROLLED STUDY; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MICRONUCLEUS; PRIORITY JOURNAL; RADIOSENSITIVITY;

BASE SEQUENCE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN; DNA DAMAGE; DNA PRIMERS; DNA REPAIR; FEMALE; G0 PHASE; GENOTYPE; HUMANS; MICRONUCLEUS TESTS; MUTATION; PROTEIN-SERINE-THREONINE KINASES; RADIATION TOLERANCE;

EID: 28744443477     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2005.04.017     Document Type: Article

References (50)

1. M. Allinen, P. Huusko, S. Mäntyniemi, Launonen, and R. Winqvist Mutation analysis of the CHK2 gene in families with hereditary breast cancer Br J Cancer 85 2001 209 212
2. *1100delC in noncarriers of BRCA1 or BRCA2 mutations Nat Genet 31 2002 55 59
3. H. Meijers-Heijboer, J. Wijnen, H. Vasen, M. Wasielewski, A. Wagner, A. Hollestelle, F. Elstrodt, R. van den Bos, A. de Snoo, G.T. A Fat, C. Brekelmans, S. Jagmohan, P. Franken, P. Verkuijlen, A. van den Ouweland, P. Chapman, C. Tops, G. Möslein, J. Burn, H. Lynch, J. Klijn, R. Fodde, and M. Schutte The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype Am J Hum Genet 72 2003 1308 1314
4. S. Ingvarsson, B.I. Sigbjornsdottir, C. Huiping, S.H. Hafsteinsdottir, G. Ragnarsson, R.B. Barkardottir, A. Arason, V. Egilsson, and J.T. Bergthorsson Mutation analysis of the CHK2 gene in breast carcinoma and other cancers Breast Cancer Res 4 2002 R4
5. N. Sodha, S. Bulloch, R. Taylor, G. Mitchell, B. Guerti-Lackner, R.D. Williams, S. Bevan, K. Bishop, S. McGuire, R.S. Houlston, and R.A. Eeles CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours Br J Cancer 87 2002 1445 1448
6. P. Vahteristo, J. Bartkova, H. Eerola, K. Syrjäkoski, S. Ojala, O. Kilpivaara, A. Tamminen, J. Kononen, K. Aittomäki, P. Heikkilä, K. Holli, C. Blomqvist, J. Bartek, O.P. Kallioniemi, and H. Nevanlinna A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer Am J Hum Genet 71 2002 432 438
7. R.A. Oldenburg, K. Kroeze-Jansema, J. Kraan, H. Morreau, J.G. Klijn, N. Hoogerbrugge, M.J. Ligtenberg, C.J. van Asperen, H.F.A. Vasen, C. Meijers, H. Meijers-Heijboer, T.H. de Bock, C.J. Cornelisse, and P. Devilee The CHEK2 1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families Cancer Res 63 2003 8153 8157
8. M. Schutte, S. Seal, R. Barfoot, H. Meijers-Heijboer, M. Wasielewski, D.G. Evans, D. Eccles, C. Meijers, F. Lohman, J. Klijn, A. van den Ouweland, The Breast Cancer Linkage Consortium, P.A. Futreal, K.L. Nathanson, B.L. Weber, D.F. Easton, M.R. Stratton, and N. Rahman Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility Am J Hum Genet 72 2003 1023 1028
9. CHEK2 Breast Cancer Case-Control Consortium. CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10860 breast cancer cases and 9065 controls from 10 studies. Am J Hum Genet 2004;74:1175-1182.
10. D.M. Friedrichsen, K.E. Malone, D.R. Doody, J.R. Daling, and E.A. Ostrander Frequency of CHEK2 mutations in a population based, case-control study of breast cancer in young women Breast Cancer Res 6 2004 R629 R635
11. B.E. Baysal, J.A. DeLoia, J.E. Willett-Brozick, M.T. Goodman, M.F. Brady, F. Modugno, H.T. Lynch, Y.P. Conley, P. Watson, and H.H. Gallion Analysis of CHEK2 gene for ovarian cancer susceptibility Gynecol Oncol 95 2004 62 69
12. X. Dong, L. Wang, K. Taniguchi, X. Wang, J.M. Cunningham, S.K. McDonnell, C. Qian, A.F. Marks, S.L. Slager, B.J. Peterson, D.I. Smith, J.C. Cheville, M.L. Blute, S.J. Jacobsen, D.J. Schaid, D.J. Tindall, S.N. Thibodeau, and W. Liu Mutations in CHEK2 associated with prostate cancer risk Am J Hum Genet 72 2003 270 280
13. E.H. Seppälä, T. Ikonen, N. Mononen, V. Autio, A. Rökman, M.P. Matikainen, T.L.J. Tammela, and J. Schleutker CHEK2 variants associate with hereditary prostate cancer Br J Cancer 89 2003 1966 1970
14. L. Lipton, C. Fleischmann, O.M. Sieber, H.J.W. Thomas, S.V. Hodgson, I.P.M. Tomlinson, and R.S. Houlston Contribution of the CHEK2 1100delC variant to risk of multiple colorectal adenoma and carcinoma Cancer Lett 200 2003 149 152
15. K. Offit, H. Pierce, T. Kirchhoff, P. Kolachana, B. Rapaport, P. Gregersen, S. Johnson, O. Yossepowitch, H. Huang, J. Satagopan, M. Robson, L. Scheuer, K. Nafa, and N. Ellis Frequency of CHEK2 1100delC in New York breast cancer cases and controls BMC Med Genet 4 2003 1
16. M.A. Caligo, S. Agata, G. Aceto, R. Crucianelli, S. Manoukian, B. Peissel, M.C. Scaini, E. Sensi, S. Veschi, A. Cama, P. Radice, A. Viel, E. D'Andrea, and M. Montagna The CHEK2 1100delC mutation plays an irrelevant role in breast cancer predisposition in Italy Hum Mutat 24 2004 100 101
17. M.R. Dufault, B. Betz, B. Wappenschmidt, W. Hofmann, K. Bandick, A. Golla, A. Pietschmann, C. Nestle-Kramling, K. Rhiem, C. Huttner, C. Von Lindern, P. Dall, M. Kiechle, M. Untch, W. Jonat, A. Meindl, S. Scherneck, D. Niederacher, R.K. Schmutzler, and N. Arnold Limited relevance of the CHEK2 gene in hereditary breast cancer Int J Cancer 110 2004 320 325
18. A. Osorio, R. Rodríguez-Lopez, O. Diéz, M. de la Hoya, J.I. Martínez, A. Vega, E. Esteban-Cardeñosa, C. Alonso, T. Caldés, and J. Benítez The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population Int J Cancer 108 2004 54 56
19. *1100delC in unselected series of non-BRCA1/2 male breast cancers Int J Cancer 108 2004 477 478
20. *1100delC and male breast cancer risk in Israel Int J Cancer 108 2004 479 480
21. K. Syrjakoski, T. Kuukasjarvi, A. Auvinen, and O.P. Kallioniemi CHEK2 1100delC is not a risk factor for male breast cancer population Int J Cancer 108 2004 475 476
22. A. Broeks, L. de Witte, A. Nooijen, A. Huseinovic, J.G.M. Klijn, F.E. van Leeuwen, N.S. Russell, and L.J. van't Veer Excess risk for contralateral breast cancer in CHEK2 1100delC germline mutation carriers Breast Cancer Res Treat 83 2004 91 93
23. B. Kuschel, A. Auranen, C.S. Gregory, N.E. Day, D.F. Easton, B.A.J. Ponder, A.M. Dunning, and P.D.P. Pharoah Common polymorphisms in checkpoint kinase 2 are not associated with breast cancer risk Cancer Epidemiol Biomarkers Prev 12 2003 809 812
24. O. Kilpivaara, P. Vahteristo, J. Falck, K. Syrjakoski, H. Eerola, D. Easton, J. Bartkova, J. Lukas, P. Heikkila, K. Aittomaki, K. Holli, C. Blomqvist, O.P. Kallioniemi, J. Bartek, and H. Nevanlinna CHEK2 variant I157T may be associated with increased breast cancer risk Int J Cancer 111 2004 543 547
25. B.B.S. Zhou, and S.J. Elledge The DNA damage response: putting checkpoints in perspective Nature 408 2000 433 439
26. J. Bartek, J. Falck, and J. Lukas CHK2 kinase: a busy messenger Nat Rev Mol Cell Biol 2 2001 877 886
27. J. Ahn, M. Urist, and C. Prives The Chk2 protein kinase DNA Repair 3 2004 1039 1047
28. S. Matsuoka, M.X. Huang, and S.J. Elledge Linkage of ATM to cell cycle regulation by the Chk2 protein kinase Science 282 1998 1893 1897
29. S. Matsuoka, G. Rotman, A. Ogawa, Y. Shiloh, K. Tamai, and S.J. Elledge Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro Proc Natl Acad Sci U S A 97 2000 10389 10394
30. N.H. Chehab, A. Malikzay, M. Appel, and T.D. Halazonetis Chk2/hCds1 functions as a DNA damage checkpoint in G1 by stabilizing p53 Gene Dev 14 2000 278 288
31. J.S. Lee, K.M. Collins, A.L. Brown, C.H. Lee, and J.H. Chung hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response Nature 404 2000 201 204
32. J. Falck, N. Mailand, R.G. Syljuasen, J. Bartek, and J. Lukas The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis Nature 410 2001 842 847
33. D. Scott, J.B.P. Barber, A.R. Spreadborough, W. Burrill, and S.A. Roberts Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays Int J Radiat Biol 75 1999 1 10
34. A. Baeyens, H. Thierens, K. Claes, B. Poppe, L. Messiaen, L. De Ridder, and A. Vral Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition Br J Cancer 87 2002 1379 1385
35. A. Baeyens, R. Van Den Broecke, A. Makar, H. Thierens, L. De Ridder, and A. Vral Chromosomal radiosensitivity in breast cancer patients: influence of age of onset of the disease Oncol Rep 13 2005 347 354
36. L.A. Jones, D. Scott, R. Cowan, and S.A. Roberts Abnormal radiosensitivity of lymphocytes from breast cancer patients with excessive normal tissue damage after radiotherapy: chromosome aberrations after low dose-rate irradiation Int J Radiat Biol 67 1995 519 528
37. R. Parshad, F.M. Price, V.A. Bohr, K.H. Cowans, J.A. Zujewski, and K.K. Sanford Deficient DNA repair capacity, a predisposing factor in breast cancer Br J Cancer 74 1996 1 5
38. R.K. Patel, A.H. Trivedi, D.C. Arora, J.M. Bhatavdekar, and D.D. Patel DNA repair proficiency in breast cancer patients and their first-degree relatives Int J Cancer 73 1997 20 24
39. D. Scott, A. Spreadborough, E. Levine, and S.A. Roberts Genetic predisposition in breast cancer [Letter] Lancet 344 1994 1444
40. D. Scott, J.B.P. Barber, E.L. Levine, W. Burrill, and S.A. Roberts Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients: a test for predisposition? Br J Cancer 77 1998 614 620
41. G.I. Terzoudi, T. Jung, J. Hain, J. Vrouvas, K. Margaritis, C. Donta-Bakoyiannis, V. Makropoulos, P.H. Angelakis, and G.E. Pantelias Increased chromosomal radiosensitivity in cancer patients: the role of cdk1/cyclin-B activity level in the mechanisms involved Int J Radiat Biol 76 2000 607 615
42. K. Baria, C. Warren, S.A. Roberts, C.M. West, and D. Scott Chromosomal radiosensitivity as a marker of predisposition to common cancers? Br J Cancer 84 2001 892 896
43. T.A. Buchholz, and X. Wu Radiation-induced chromatid breaks as a predictor of breast cancer risk Int J Radiat Oncol Biol Phys 49 2001 533 537
44. A.C. Riches, P.E. Bryant, C.M. Steel, A. Gleig, A.J. Robertson, P.E. Preece, and A.M. Thompson Chromosomal radiosensitivity in G2-phase lymphocytes identifies breast cancer patients with distinctive tumour characteristics Br J Cancer 85 2001 1157 1161
45. A. Baeyens, H. Thierens, K. Claes, B. Poppe, L. De Ridder, and A. Vral Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers Int J Radiat Biol 80 2004 745 756
46. K. Claes, B. Poppe, I. Coene, A. De Paepe, and L. Messiaen BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families Br J Cancer 90 2004 1244 1251
47. N. Sodha, R.S. Houlston, R. Williams, M.A. Yuille, J. Mangion, and R.A. Eeles A robust method for detecting CHK2/RAD53 mutations in genomic DNA Hum Mutat 19 2002 173 177
48. G. Speit, and K. Trenz Chromosomal mutagen sensitivity associated with mutations in BRCA genes Cytogenet Genome Res 104 2004 325 332
49. M. Takata, M.S. Sasaki, E. Sonoda, C. Morrison, M. Hashimoto, H. Utsumi, Y. Yamaguchi-Iwai, A. Shinohara, and S. Takeda Homologous recombination and nonhomologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells EMBO J 17 1998 5497 5508
50. K. Rothkamm, M. Kühne, P.A. Jeggo, and M. Löbrich Radiation-induced genomic rearrangements formed by nonhomologous end joining of DNA double-strand breaks Cancer Res 61 2001 3886 3893